Cargando…
Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques()
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS on behalf of Société Française de Rhumatologie.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529531/ https://www.ncbi.nlm.nih.gov/pubmed/34697532 http://dx.doi.org/10.1016/j.rhum.2021.10.560 |
| _version_ | 1784586489111248896 |
|---|---|
| author | Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka |
| author_facet | Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka |
| author_sort | Richette, Pascal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8529531 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Masson SAS on behalf of Société Française de Rhumatologie. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85295312021-10-21 Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques() Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka Rev Rhum Ed Fr Lettre À La Rédaction Published by Elsevier Masson SAS on behalf of Société Française de Rhumatologie. 2022-05 2021-10-21 /pmc/articles/PMC8529531/ /pubmed/34697532 http://dx.doi.org/10.1016/j.rhum.2021.10.560 Text en © 2021 Published by Elsevier Masson SAS on behalf of Société Française de Rhumatologie. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Lettre À La Rédaction Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques() |
| title | Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques() |
| title_full | Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques() |
| title_fullStr | Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques() |
| title_full_unstemmed | Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques() |
| title_short | Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques() |
| title_sort | impact de la covid-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques() |
| topic | Lettre À La Rédaction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529531/ https://www.ncbi.nlm.nih.gov/pubmed/34697532 http://dx.doi.org/10.1016/j.rhum.2021.10.560 |
| work_keys_str_mv | AT richettepascal impactdelacovid19surlinitiationdesprescriptionsdesbiotherapiesdanslesmaladiesinflammatoireschroniques AT allezmatthieu impactdelacovid19surlinitiationdesprescriptionsdesbiotherapiesdanslesmaladiesinflammatoireschroniques AT descampsvincent impactdelacovid19surlinitiationdesprescriptionsdesbiotherapiesdanslesmaladiesinflammatoireschroniques AT perraylucas impactdelacovid19surlinitiationdesprescriptionsdesbiotherapiesdanslesmaladiesinflammatoireschroniques AT piletsimon impactdelacovid19surlinitiationdesprescriptionsdesbiotherapiesdanslesmaladiesinflammatoireschroniques AT latourteaugustin impactdelacovid19surlinitiationdesprescriptionsdesbiotherapiesdanslesmaladiesinflammatoireschroniques AT maravicmilka impactdelacovid19surlinitiationdesprescriptionsdesbiotherapiesdanslesmaladiesinflammatoireschroniques |